Crossmark

Prognostic value of an automated bone scan index for men with metastatic castration-resistant prostate cancer treated with cabazitaxel

Crossref DOI link: https://doi.org/10.1186/s12885-018-4401-y

Published Online: 2018-05-02

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Uemura, Koichi

Miyoshi, Yasuhide https://orcid.org/0000-0001-8857-9798
Kawahara, Takashi

Ryosuke, Jikuya

Yamashita, Daisuke

Yoneyama, Shuko

Yokomizo, Yumiko

Kobayashi, Kazuki

Kishida, Takeshi

Yao, Masahiro

Uemura, Hiroji
License Information

Text and Data Mining valid from 2018-05-02
More Information

Article History

Received: 28 December 2017

Accepted: 18 April 2018

First Online: 2 May 2018

Ethics approval and consent to participate

: The Institutional Review Board of Yokohama City University Medical Center approved this study. Informed consent to participate in the study was obtained from the subjects.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.